Treatment outcome with a second generation combination chemotherapeutic regimen m-BACOD and with a standard regimen chop for advance diffuse non-Hodgkin’s lymphoma in elderly patients. J. Armed Forces Med. Coll. 2009;4(2):27-32. doi:10.3329/jafmc.v4i2.1842